Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001897612-26-000276·T. Rowe Price Investment Management, Inc.
Schedule 13G ownership disclosure
Vaxcyte Inc
COMMON STOCK · CUSIP: 92243G108
Event date: 2025-12-31
- Filing-level shares
- 11,296,333
- Percent of class
- 8.6%
- T. Rowe Price Investment Management, Inc.
Shares: 11,296,333 · Class: 8.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-26-000276
- Form type
- SCHEDULE 13G/A
- Filer
- T. Rowe Price Investment Management, Inc.
- CIK
- CIK 1897612
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership